The TARGIT Collaborative Group (TCG)

The TARGIT Collaborative Group (TCG) is a cooperative effort between radiation oncologists, cancer surgeons, physicists and other experts in intraoperative radiotherapy who share a common commitment to improving cancer patient care through education, patient advocacy, mentorship and collaborative research.

The International TARGIT Research Group

Since 1996, the international TARGIT research group has been researching a new method of radiotherapy for breast cancer in which the treatment can be reduced to a single radiation exposure.

For a complete list of scientific publications, please visit the TARGIT literature archive (1995-2018): https://www.targit.org.uk/publications

British Medical Journal

August 19, 2020

Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial.


 

Loyola University Medical Center, Maywood, IL, United States

March 26, 2018

Study: Intraoperative Radiotherapy With INTRABEAM: Technical and Dosimetric Considerations